Vincenzo Quagliariello
Overview
Explore the profile of Vincenzo Quagliariello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1080
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fazzini L, Campana N, Cossu S, Deidda M, Madaudo C, Quagliariello V, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004816
Emerging evidence indicates that specific genetic variants are associated with an increased risk of toxicity from anticancer treatments and cancer-related cardiovascular complications. These genetic factors influence drug metabolism, efficacy, and...
2.
Ottaiano A, Facchini B, Iacovino M, Santorsola M, Facchini S, Di Mauro G, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766105
Breast cancer remains the leading cause of cancer-related deaths among women despite advances in early detection. Neoadjuvant chemotherapy (NACT) is now standard for early-stage BC, with vitamin D (VD) emerging...
3.
Quagliariello V, Canale M, Bisceglia I, Iovine M, Giordano V, Giacobbe I, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39457081
Cancer patients, especially long cancer survivors, are exposed to several cardio-metabolic diseases, including diabetes, heart failure, and atherosclerosis, which increase their risk of cardiovascular mortality. Therapy with glucagon-like peptide 1...
4.
Wahab M, Del Gaudio N, Gargiulo B, Quagliariello V, Maurea N, Nebbioso A, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272883
Epigenetic changes regulate gene expression through histone modifications, chromatin remodeling, and protein translation of these modifications. The PRC1 and PRC2 complexes shape gene repression via histone modifications. Specifically, the CBX...
5.
Serri C, Quagliariello V, Cruz-Maya I, Guarino V, Maurea N, Giunchedi P, et al.
Pharmaceutics
. 2024 Aug;
16(8).
PMID: 39204330
Anthracycline-based therapies exert endothelial damages through peroxidation and the production of proinflammatory cytokines, resulting in a high risk of cardiovascular complications in cancer patients. Hyaluronic acid-based hybrid nanoparticles (LicpHA) are...
6.
Quagliariello V, Canale M, Bisceglia I, Maurea C, Gabrielli D, Tarantini L, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200115
Cardiovascular disease and cancer are the two leading causes of morbidity and mortality in the world. The emerging field of cardio-oncology described several shared risk factors that predispose patients to...
7.
Bisceglia I, Venturini E, Canale M, Ambrosetti M, Riccio C, Giallauria F, et al.
Eur Heart J Suppl
. 2024 May;
26(Suppl 2):ii252-ii263.
PMID: 38784673
Cardio-oncology rehabilitation (CORE) is not only an essential component of cancer rehabilitation but also a pillar of preventive cardio-oncology. Cardio-oncology rehabilitation is a comprehensive model based on a multitargeted approach...
8.
Quagliariello V, Berretta M, Bisceglia I, Giacobbe I, Iovine M, Giordano V, et al.
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672567
Anthracycline-induced cardiomyopathies and sarcopenia are frequently seen in cancer patients, affecting their overall survival and quality of life; therefore, new cardioprotective and anti-sarcopenic strategies are needed. Vericiguat is a new...
9.
Bisceglia I, Venturini E, Canale M, Ambrosetti M, Riccio C, Giallauria F, et al.
G Ital Cardiol (Rome)
. 2024 Mar;
25(4):281-293.
PMID: 38526365
Cardio-oncology rehabilitation (CORE) is not only an essential component of cancer rehabilitation, but also a pillar of preventive cardio-oncology. CORE is a comprehensive model based on a multitargeted approach and...
10.
Ottaiano A, Iacovino M, Santorsola M, Facchini S, Iervolino D, Perri F, et al.
J Transl Med
. 2024 Jan;
22(1):119.
PMID: 38291479
Background: Vitamin D (VD) is implicated in various health conditions, including colorectal cancer (CRC). To investigate potential relationships between pre-chemotherapy VD levels and the time-to-outcome in metastatic CRC patients, we...